Mission

ICER's mission is to lead innovation in comparative effectiveness research through methods that integrate considerations of clinical benefit and economic value.  Through a unique collaboration with patients, clinicians, manufacturers, insurers and other healthcare stakeholders, ICER develops tools to support patient decisions and medical policy that share the goal of achieving maximum value for every healthcare dollar.

Staff Only

Remember Me
ICER quoted in article on resistance to changes in established medical practice

Changes to established medicine hit resistance
By Keith Darcé
The San Diego Union-Tribune

December 13, 2009 - Breast cancer survivor Barbara Schaeffer advocates early screening.

The head of the federal panel that recommended fewer breast-cancer screenings for women younger than 50 was unapologetic when he addressed members of Congress recently.  “Our message was misunderstood,” Dr. Bruce “Ned” Calonge said. “The task force stands behind the evidence and the conclusions based on the evidence.” His resolute words didn’t mute Carlsbad resident Barbara Schaeffer’s outrage.

Read more from the San Diego Union-Tribune.